This study is completed in the United States, in Belgium, in Bulgaria, .... It is testing pharmacokinetics, Safety, and Tolerability of Paliperidone Palmitate for schizophrenia.
In Belgium
SchizophreniaDrugA study involving a medication or substance.From 18 Years to 65 Years
This study is completed in France, in the United Kingdom, in Switzerland, .... It is testing Effectiveness and Safety of Prolonged Release OROS Methylphenidate for ADHD.
This study is completed in the United States, in France, in Canada, .... It is testing efficacy, Safety, and Tolerability of Fixed Doses of Intranasal Esketamine Plus an Oral Antidepressant for treatment-resistant depression.
This study is completed in the United States, in France, in the United Kingdom, .... It is testing efficacy, Safety, and Tolerability of Intranasal Esketamine Plus an Oral Antidepressant for treatment-resistant depression.
This study is completed in the United States, in Belgium, and in Japan. It is testing safety and Efficacy of Intranasal Esketamine for treatment-resistant depression.
This study is completed in the United States, in Belgium, in Germany, .... It is testing safety and the Effects of Risperidone Compared With Other Atypical Antipsychotic Drugs on the Growth and Sexual Maturation for Schizophrenia.
In Belgium
Schizophrenia, BipolarityDrugFrom 8 Years to 16 Years
Countries
United States, Belgium, Germany, ...
Sponsor
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
This study exists to compare options and see whether a therapy or guided support program offers something meaningfully different. Researchers are trying to understand what a therapy or guided support program could change in day-to-day care and decision-making.
This study exists to understand how this type of care holds up over time after the earliest research stage. Researchers are trying to understand how people respond to this type of care in practice and what may need to be adjusted.
HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.